Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting

Data ReadoutpositiveRESTORE-PVPositive

AI Analysis

Summary

Disc Medicine presented initial results from the RESTORE-PV Phase 2 trial evaluating treatment in polycythemia vera patients at the SOHO Annual Meeting. The positive data presentation represents progress in the clinical development program.

Clinical Trial Data

Phase

Phase 2

Outcome Details

Initial results presented

Importance:6/10

Sentiment:

0.60

Phase 2 datahematologic oncologypolycythemia veraconference presentation

Related Companies

$IRON

Read the original article

Published by yahoo_finance on September 9, 2026 11:25 PM

Read Original